Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-analysis.

ABSTRACT:

Background

Middle meningeal artery embolization is an emerging treatment option for chronic subdural hematomas.

Purpose

Our aim was to assess outcomes following middle meningeal artery embolization by different techniques, including in comparison with traditional surgical methods.

Data sources

We searched the literature databases from inception to March 2022.

Data selection

We selected studies reporting outcomes after middle meningeal artery embolization as a primary or adjunctive treatment for chronic subdural hematoma.

Data analysis

We analyzed the risk of recurrence of chronic subdural hematoma, reoperation for recurrence or residual hematoma, complications, and radiologic and clinical outcomes using random effects modeling. Additional analyses were p

SUBMITTER: Ku JC 

PROVIDER: S-EPMC10187811 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature